‘Text/HTML’ of page ‘NRG-GI005: The COBRA Trial’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-GI005: The COBRA Trial
‘Text/HTML’ of page ‘NRG-GI005: The COBRA Trial’
Am I eligible for this study? You are eligible for this study if you have early-stage (Stage IIA) colon cancer that has been treated with surgery and your doctor would not normally recommend post-operative chemotherapy, but instead would usually follow you closely. Your healthcare team is the best source for information about your treatment options, […]
Read More‘Text/HTML’ of page ‘NRG-GI005: The COBRA Trial’
About This Study NRG-GI005, also known as the “COBRA” Study, is a clinical study for people with early-stage colon cancer that is seeking to discover if using a blood sample and testing for the presence of circulating tumor DNA (ctDNA) could help determine whether a patient should receive chemotherapy or no further treatment after receiving […]
Read More‘Text/HTML’ of page ‘NRG-GI005: The COBRA Trial’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-GI005: The COBRA Trial’
THE COBRA STUDY FAQ
Read More